Association between latent toxoplasmosis and major depression, generalised anxiety disorder and panic disorder in human adults

Folia Parasitologica

Volumn 61, Issue 4, 2014, Pages 285-292

  Gale, Shawn D ^a   Brown, Bruce L ^a   Berrett, Andrew ^a   Erickson, Lance D ^a   Hedges, Dawson W ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Behaviour; Mood; National Health and Nutrition Examination Survey (NHANES); Psychiatric; Toxoplasma gondii

Indexed keywords

TOXOPLASMA GONDII;

IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; ANXIETY DISORDER; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MAJOR DEPRESSION; MALE; PANIC; PARASITOLOGY; PATHOLOGY; RISK; RISK FACTOR; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

ADULT; ANTIBODIES, PROTOZOAN; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; ODDS RATIO; PANIC DISORDER; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 84907423941     PISSN: 00155683     EISSN: 18036465     Source Type: Journal    
DOI: 10.14411/fp.2014.038     Document Type: Article

References (38)

1. Bechara A., Damasio H., Damasio A.R. 2000: Emotion, decision making and the orbitofrontal cortex. Cereb. Cortex. 10: 295-307.
2. Berdoy M., Webster J.P., Macdonald D.W. 2000: Fatal attraction in rats infected with Toxoplasma gondii. Proc. Biol. Sci. 267: 1591-1594.
3. Berenreiterová M., Flegr J., Kubena A.A., Nemec P. 2011: The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 6: e28925.
4. Carruthers V.B., Suzuki Y. 2007: Effects of Toxoplasma gondii infection on the brain. Schizophr. Bull. 33: 745-751.
5. CDC (Centers for Disease Control) 2005: Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey [Online]. U.S. Department of Health and Human Services. World Wide Web electronic publication, www.cdc. gov/nchs/data/nhanes/nhanes_03_04/ nhanes_analytic_guidelines_ dec_2005.pdf.
6. CDC (Centers for Disease Control) 2014. Questionnaires, Datasets, and Related Documentation: The National Health and Nutrition Examination Survey (Online). U.S. Department of Health and Human Services. World Wide Web electronic publication, www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm, 02/2014.
7. Cetinkaya Z., Yazar S., Gecici O., Namli M.N. 2007: Anti- Toxoplasma gondii antibodies in patients with schizophrenia - preliminary findings in a Turkish sample. Schizophr. Bull. 33: 789-791.
8. Dubey J.P. 1998: Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 28: 1019-1024.
9. Etkin A., Wager T.D. 2007: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 164: 1476-1488.
10. Fekadu A., Shibre T., Cleare A.J. 2010: Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms. Folia Parasitol. 57: 105-113.
11. Flegr J. 2010: Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitol. 57: 81-87.
12. Flegr J. 2013: Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 216: 127-133.
13. Hamdani N., Daban-Huard C., Lajnef M., Richard J.R., Delavest M., Godin O., Guen E.L., Vederine F.E., Lepine J.P., Jamain S., Houenou J., Corvoisier P.L., Aoki M., Moins-Teisserenc H., Charron D., Krishnamoorthy R., Yolken R., Dickerson F., Tamouza R., Leboyer M. 2013: Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J. Affect. Disord. 148: 444-448.
14. Hamidinejat H., Ghorbanpoor M., Hosseini H., Alavi S.M., Nabavi L., Jalali M.H., Borojeni M.P., Jafari H., Mohammadaligol S. 2010: Toxoplasma gondii infection in firstepisode and inpatient individuals with schizophrenia. Int. J. Infect. Dis. 14: e978-981.
15. Helzer J.E., Robins L.N. 1988: The diagnostic interview schedule: its development, evolution, and use. Soc. Psychiatry Psychiatr. Epidemiol. 23: 6-16.
16. Henriquez S.A., Brett R., Alexander J., Pratt J., Roberts C.W. 2009: Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16: 122-133.
17. Hinze-Selch D., Daubener W., Eggert L., Erdag S., Stoltenberg R., Wilms S. 2007: A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull. 33: 782-788.
18. Jones J.L., Dargelas V., Roberts J., Press C., Remington J.S., Montoya J.G. 2009: Risk factors for Toxoplasma gondii infection in the United States. Clin. Infect. Dis. 49: 878-884.
19. Jones J.L., Kruszon-Moran D., Wilson M. 2003: Toxoplasma gondii infection in the United States, 1999-2000. Emerg. Infect. Dis. 9: 1371-1374.
20. Jones J.L., Kruszon-Moran D., Wilson M., Mcquillan G., Navin T., Mcauley J.B. 2001: Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am. J. Epidemiol. 154: 357-365.
21. Jones-Brando L. 2003: Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr. Res. 62: 237-244.
22. Kessler R.C., Petukhova M., Sampson N.A., Zaslavsky A.M., Wittchen H.U. 2012: Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int. J. Methods Psychiatr. Res. 21: 169-184.
23. Montoya J.G., Liesenfeld O. 2004: Toxoplasmosis. Lancet 363: 1965-1976.
24. Novotná M., Hanusová J., Klose J., Preiss M., Havlícek J., Roubalová K., Flegr J. 2005: Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect. Dis. 5: 54.
25. Pearce B.D., Kruszon-Moran D., Jones J.L. 2012: The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol. Psychiatry. 72: 290-295.
26. Pedersen M.G., Mortensen P.B., Norgaard-Pedersen B., Postolache T.T. 2012: Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psychiatry 69: 1123-1130.
27. Prandovszky E., Gaskell E., Martin H., Dubey J.P., Webster J.P., Mcconkey G.A. 2011: The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 6: e23866.
28. Skallová A., Novotná M., Kolbeková P., Gasová Z., Veselỳ V., Sechovská M., Flegr J. 2005: Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuroendocrinol. Lett. 26: 480-486.
29. Stibbs H.H. 1985: Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann. Trop. Med. Parasitol. 79: 153-157.
30. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. 2007: Antibodies to Toxoplasma gondii in patients with schizophrenia. a meta-analysis. Schizophr. Bull. 33: 729-736.
31. Tromp D.P., Grupe D.W., Oathes D.J., Mcfarlin D.R., Hernandez P.J., Kral T.R., Lee J.E., Adams M., Alexander A.L., Nitschke J.B. 2012: Reduced structural connectivity of a major frontolimbic pathway in generalized anxiety disorder. Arch. Gen. Psychiatry 69: 925-934.
32. Vasa R.A., Grados M., Slomine B., Herskovits E.H., Thompson R.E., Salorio C., Christensen J., Wursta C., Riddle M.A., Gerring J.P. 2004: Neuroimaging correlates of anxiety after pediatric traumatic brain injury. Biol. Psychiatry. 55: 208-216.
33. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., Sapolsky R.M. 2007: Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. USA 104: 6442-6447.
34. Wang H.L., Wang G.H., Li Q.Y., Shu C., Jiang M.S., Guo Y. 2006: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta. Psychiatr. Scand. 114: 40-48.
35. Webster J.P. 2007: The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr. Bull. 33: 752-756.
36. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. 2006: Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and antiparasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 273: 1023-1030.
37. Xiao J., Kannan G., Jones-Brando L., Brannock C., Krasnova I.N., Cadet J.L., Pletnikov M., Yolken R.H. 2012: Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience 206: 39-48.
38. Zhang Y., Traskman-Bendz L., Janelidze S., Langenberg P., Saleh A., Constantine N., Okusaga O., Bay-Richter C., Brundin L., Postolache T.T. 2012: Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J. Clin. Psychiatry 73: 1069-1076.